Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Multiple Doses of ASP8062 With a Single Dose of Morphine for Addiction.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 for schizophrenia.
In United StatesThis study is completed in the United States, in the United Kingdom, and in Ireland. It is testing use of Methylone for PTSD.
In United States
This study is completed in the United States. It focuses on Suicide prevention.
In United StatesThis study is completed in the United States. It focuses on Addiction.
In United StatesThis study is completed in the United States, in Brazil, and in Mexico. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It focuses on depression.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States. It is testing Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® for schizophrenia.
In United StatesThis study is completed in the United States. It focuses on schizophrenia.
In United StatesThis study is completed in the United States and in India. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It is testing 3 Different Doses of JNJ-31001074 for ADHD.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.